Skip to search formSkip to main contentSkip to account menu

BOL-303242-X

Known as: BOL 303242-X, BOL303242-X 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
PURPOSE To compare the efficacy of mapracorat (formerly ZK-245186, and subsequently BOL-303242-X), a novel selective… 
2011
2011
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist
Purpose Glucocorticoids can either suppress gene transcription (transrepression) or activate it (transactivation). This latter… 
2010
2010
Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
PURPOSE To assess in vitro myocilin (MYOC) expression in trabecular meshwork (TM) cells exposed to BOL-303242-X, a selective… 
2010
2010
BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolarity-Induced Cytokine Release in Human Corneal Epithelial Cells
2010
2010
Ocular Pharmacokinetics of BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, in Pigmented Rabbits and Cynomolgus Monkeys
2009
2009
BOL-303242-X, a Selective Glucocorticoid Receptor Agonist (SEGRA), Offers a Better in vivo Side Effect Profile Than Dexamethasone on Intraocular Pressure Elevation in Normotensive Rabbits
2009
2009
Ocular Pharmacokinetics of BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist (SEGRA), in Pigmented Rabbits
2009
2009
Effects of BOL-303242-X, a Selective Glucocorticoid Receptor Agonist (SEGRA), on Human Eosinophils and an Ocular Allergy Model
2009
2009
Efficacy of a Selective Glucocorticoid Receptor Agonist (SEGRA; BOL-303242-X) in a Rodent Model of Laser-Induced Choroidal Neovascularization
2009
2009
Anti-Inflammatory Effects of BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, in Human Ocular Cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)